Safety and Pharmacokinetics of Once-Daily Regimens of Soft-Gel Capsule Saquinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Negative Adults

Human immunodeficiency virus type 1 (HIV-1) protease inhibitors have dramatically improved treatment options for HIV infection, but frequent dosing may impact adherence to highly active antiretroviral treatment regimens (HAART). Previous studies demonstrated that combined therapy with ritonavir and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kilby, J. Michael, Sfakianos, Greg, Gizzi, Nick, Siemon-Hryczyk, Peggy, Ehrensing, Eric, Oo, Charles, Buss, Neil, Saag, Michael S.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2000
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC90133/
https://ncbi.nlm.nih.gov/pubmed/10991842
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares